Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00503685
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2007-07-17
Brief Title:
Study Using IMC-A12 Cixutumumab With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-17
First Submit QC Date:
July 18 2007
Study First Post Date:
2007-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-10-12
Disp First Submit QC Date:
October 12 2010
Disp First Post Date:
2010-10-19
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-05-02
Last Update Post Date:
2018-06-06
Last Update Post Date Type:
ACTUAL